Australia's most trusted
source of pharma news
![]() |
Posted 11 June 2024 PM
Pharma industry professionals are experiencing a surge in confidence about the sector's growth prospects over the next 12 months, with 73 per cent feeling 'optimistic' or 'very optimistic' - an increase of 13 per cent on sentiment just six months ago.
According to GlobalData's, State of the Biopharmaceutical Industry 2024 Mid-Year Update, only seven per cent of those surveyed felt 'pessimistic' or 'very pessimistic' while further 20 per cent felt neutral - neither optimistic nor pessimistic. Although the upward trend is considered a positive sign, GlobalData said it remains considerably lower than 2022 when 81 per cent of respondents felt confident about growth.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.